Kiran Mazumdar-Shaw recognised among world's top 20 inspirational leaders in Biopharma
The self-made billionaire has been recognised for her contribution to the world of medicine as an entrepreneur and innovative business leader in The Medicine Maker Power List 20 for six consecutive years since 2015.
Biocon Ltd announced on Monday that The Medicine Maker Power List 2020 has ranked its Executive Chairperson Kiran Mazumdar-Shaw as one of the world's top 20 inspirational leaders in the field of biopharmaceuticals.
She has been recognised for her contribution to the world of medicine as an entrepreneur and innovative business leader, the Bengaluru-headquartered biopharmaceuticals company said in a statement.
The Medicine Maker Power List 20 for 2020 celebrates 60 great minds who have brought the world innovation in small molecules, biopharmaceuticals and advanced medicine, it said.
It highlights professionals who are driving the industry forward and saving lives by developing new medicines and lending a helping hand in bringing COVID-19 vaccines and treatments to market as soon as possible, according to the statement.
Kiran Mazumdar-Shaw has been featuring on the list for six consecutive years since 2015.
She said it is indeed an honour to be featured on the List alongside G V Prasad and other remarkable and inspirational individuals whose work has positively influenced the fields of small molecules, biopharmaceuticals and advanced medicine.
"At a time when humanity is threatened by a deadly viral pandemic, the world is looking at the medical sciences to get us through the crisis."
The medical science community has risen to the challenge, sharing knowledge of potential treatments, coordinating clinical trials, developing new models of cooperation, and publishing findings immediately to tackle the COVID-19 pandemic," she said.
The self-made biotech billionaire has also expressed the possibility of getting a Made-In-India biocon in a year.
In an exclusive interview with Shradha Sharma, Founder and CEO of YourStory, Kiran Mazumdar Shaw said, "One of the reassuring aspects of the data which needs to be verified is that we are not seeing any serious cases in the ICU category. And that is what we need to track because if we have too much in that category, it will overwhelm our healthcare workers."
Further, "I hope that in 21 days, which is the time required for those in quarantine will either recover fully or show up as negative, will start giving us social immunity and hopefully stop the disease," she added.
(Disclaimer: Additional background information has been added to this PTI copy for context)